Brain Imaging and Treatment Studies of the Night Eating Syndrome

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effectiveness of the anti-depressant Lexapro in the treatment of the Night Eating Syndrome.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Pennsylvania
• Collaborator: Forest Laboratories
• Treatments: Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• men and women suffering from NES

• ages 18 to 70 years

• BMI greater than 18.5 kg/m2

Exclusion Criteria:

• Children or adolescents <18 years

• persons older than 70

• patients with diabetes mellitus

• thyroid disease and other endocrine and metabolic disorders

• use within the past month of any psychotropic medication, oral steroids, diuretics or hypnotics

• current anorexia nervosa or bulimia nervosa

• participation in an organized weight reduction program

• use of antiobesity medication

• an occupation that involves night shifts or other unusual time requirements -Major Depressive Disorder (judged severe)

• Bipolar Disorder

• suicidal risk

• current or past psychosis

• substance use or abuse disorder within the past 6 months